For Patients
Introduction to the Marshall Protocol
Length of the MP
Immunopathology
Managing immunopathology
Food and drink
Light restriction
Vitamin D metabolite calculator -
get feedback on vitamin D results
Therapeutic probe -
best method for determining MP suitability
Starting the Marshall Protocol
Resources for patients
Marshall Protocol summary
Palliative vs. curative treatments
Patient interviews on Bacteriality
Non-MP treatments
Glossary
The Protocol
Marshall Protocol summary
Publications and presentations
Science behind immunopathology
Science behind olmesartan (Benicar)
Safety of olmesartan
Resources for physicians
Vitamin D metabolite calculator -
get feedback on vitamin D results
Therapeutic probe -
best method for determining MP suitability
Physicians' concerns about the MP
Notice for emergency medical personnel
The Pathogenesis
Publications and presentations
Science behind Marshall Pathogenesis
Microbes in the human body
Successive infection and variability in disease
Autoimmune theory of disease
Science behind vitamin D
Metabolism of vitamin D and the VDR
Th1 Spectrum Disorder -
how chronic inflammatory diseases are related
Transmission of bacteria and onset of chronic disease
Evolutionary perspective on disease
Incidence and prevalence of disease
Evidence that chronic disease is caused by pathogens
Diseases
Chronic fatigue syndrome
Chronic Lyme disease
Sarcoidosis
Fibromyalgia
Multiple chemical sensitivity
Cardiovascular diseases
Cancer
Anemia
Complete List of Diseases
Foundation
Autoimmunity Research Foundation
Ways To Contribute
History Timeline
Related Sites
Autoimmunity Research Video Resources
MarshallProtocol.com
Microbeminded.com
You are here:
Welcome to the MPKB
»
Welcome to the MPKB
»
Health, food and drink
Sitemap
This is a sitemap over all available pages ordered by
namespaces
.
home
alternate
arf
devel
diseases
food
lifestyle
mp
othertreatments
pathogenesis
patients
physicians
protocol
publications
Poster - Web 2.0 offers new opportunities for patient care and research
Paper - Vitamin D: the alternative hypothesis
Poster - Multiple reports of symptom exacerbation on immunostimulatory treatment for autoimmune disease
Applications to the FDA for orphan drug status for Marshall Protocol medications
Poster - Bipolar disorders and autoimmune disease share a similar etiology
Paper - Vitamin D metabolites as clinical markers in autoimmune and chronic disease
Presentation - Olmesartan medoxomil & treatment of autoimmune disease
Presentation - Vitamin D metabolites as clinical markers in autoimmune and chronic illness
Presentation - Psychiatric and neurologic comorbidities as systemic dysfunctions
Poster - Immunostimulation: a treatment innovation in chronic inflammatory and autoimmune disorders
Paper - Electrosmog and autoimmune disease
Poster - Clinical observation of immunostimulation in chronic nervous and immune disorders: retargeted olmesartan medoxomil in 62 patients
Presentation - Treatment of chronic fatigue syndrome as an immune disorder
Paper - Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis
Poster - Monitoring cognitively-impaired subjects in an interactive Internet-based clinical trial of a multi-factorial treatment based on a molecular model of chronic disease
Presentation - Autoimmune Disease succumbs to a VDR Nuclear Receptor Agonist
Presentation - How borrelia evades the immune system, and how we help the immune system kill this Th1 bacterium
Presentation - Autoantibodies - are they the cause of disease, or the result of disease?
Presentation - The VDR nuclear receptor is key to understanding ‘diseases of the aging’
Presentation - A new approach to treating intraphagocytic CWD bacterial pathogens in sarcoidosis, CFS, Lyme and other inflammatory diseases
Presentation - Olmesartan overcomes antibiotic resistance, inducing recovery from advanced autoimmune disease
Paper - Sarcoidosis succumbs to antibiotics: implications for autoimmune disease
Presentation - Molecular mechanisms driving the current epidemic of chronic disease
Paper - Vitamin D discovery outpaces FDA decision making
Presentation - The VDR nuclear receptor is a novel proxy for MTSS1 and MTUS1 in breast, bladder and colorectal cancers
Presentation - The Marshall Protocol in a Clinical Environment - Observations from the Initial Cohort
Presentation - It is time to bury Koch - Infectious disease transitions to an understanding of the Metagenome
Presentation - Understanding human disease requires study of a metagenome, not just the human genome
Presentation - VDR receptor competence induces recovery from chronic autoimmune disease
Poster - VDR Nuclear Receptor competence is the key to recovery from chronic inflammatory and autoimmune disease
Poster - Molecular static and dynamic analyses reveal flaw in murine model used by US FDA to detect drug carcinogenicity
Poster - VDR nuclear receptor is key to recovery from cognitive dysfunction
Presentation - What more is there to discover about Vitamin D?
Presentation - The human microbiome lies at the heart of autoimmune disease
Presentation - Electrosmog Radiation - Its effects on the human VDR (and beyond)
Presentation - Molecular genomics offers new insight into the exact mechanism of action of common drugs: ARBs, statins and corticosteroids
Presentation - Is there a role for a Tin-Foil hat in PPPM?
Presentation - The microbiome, which feeds a myriad of autoimmune diseases
Presentation - What can microbial genomes tell us about human health?
Poster - Bacterial capnine blocks transcription of human antimicrobial peptides
Presentation - Environmental Radiation modulates symptoms in Human Immune Disease
Presentation - The human microbiome is the mechanism fueling neurodegenerative disorders
Presentation - Chronic Disease, the Human Microbiome, and Personalized Medicine
Presentation - The Endomicrobiome as a strategic tool of PPPM
Presentation - The importance of the microbiome in chronic disease prevention
Presentation - Immune Disease and the Microbiome: PPPM Healthcare in response to New Knowledge
Presentation - Can Waves Cause or Cure Disease?
Paper - Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b
Presentation - The Marshall Protocol in a clinical environment – observations from the initial cohort
Presentation - Why does Vitamin-D 'Work' So Well
Survey of Marshall Protocol patients with autoimmune diagnoses (2008)
Presentation - Bacteria induced vitamin D receptor dysfunction in autoimmune disease: theoretical and practical implications for interpretation of serum vitamin D metabolite levels
Paper - Dysregulation of the Vitamin D Nuclear Receptor may contribute to the higher prevalence of some autoimmune diseases in women
Presentation - Metagenomic symbiosis between bacterial and viral pathogens in autoimmune disease
Paper - Autoimmune disease in the era of the metagenome
Presentation - Vitamin D induced dysregulation of nuclear receptors may account for higher prevalence of some autoimmune diseases in women
Paper - The human microbiome and autoimmunity
Poster - Cognitive dysfunction in women with chronic fatigue syndrome: examining the role of the endometrium, the nuclear receptors, and the antimicrobial peptides
Paper - Inflammatory disease and the human microbiome
Paper - Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes.
Paper - Re-framing the Theory of Autoimmunity in the Era of the microbiome: Persistent Pathogens, Autoantibodies, and Molecular Mimicry
Paper - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity.
Poster - Successive infection: a model for how metagenomic communities shift to become more pathogenic over time
Presentation - Antibodies and infection in the era of metagenome
Book chapter - Autoimmune disease and the human metagenome
Paper - Immunostimulation in the era of the metagenome
Paper - Reversing bacteria-induced Vitamin D Receptor dysfunction is key to autoimmune disease
Article - The Marshall Protocol for Lyme Disease and other chronic inflammatory conditions
Book chapter - High levels of active 1,25-dihydroxyvitamin D despite low levels of the 25-hydroxyvitamin D precursor: implications of dysregulated vitamin D for diagnosis and treatment of chronic disease
Presentation - Vitamins D in chronic disease
social
special
starting
symptoms
tests
translations
videos
waves
Alternative models for chronic disease
Autoimmunity Research Foundation
Development
Diseases
Health, food and drink
Immune suppressive environments
Site map
Lifestyle modifications
Marshall Protocol
Non-MP therapies
Science behind Pathogenesis
Resources for patients
Resources for physicians
Science behind Marshall Paradigm
Publications & presentations
Search the MPKB
Search the MPKB
Social and psychological aspects
Special issues
Starting the Marshall Protocol
Symptoms
Laboratory tests
Translations of Marshall Protocol
Members-Only Videos
Can Waves Make You Sicker?
ncbi_esummary
playground
wiki
Welcome to the MPKB
News and highlights
home/food.txt
· Last modified: 09.14.2022 by
127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.